MBX Biosciences, Inc. business relationships
Companies named in MBX Biosciences, Inc.’s 10-K filed 2026-03-12, and public companies whose annual reports name MBX Biosciences, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- <1 / 100 Top 6% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Layers: PeptidesGLP-1 & obesity
Named in MBX Biosciences, Inc.’s annual report 1
“Petrelintide, a long-acting, once-weekly amylin analog currently in Phase 2b clinical development, is being jointly developed in collaboration with Roche.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.